StockData
Takeda Pharmaceutical Co Ltd logo

Takeda Pharmaceutical Co Ltd (TAK) stock

TAKNYSEPharmaceutical PreparationsAlso trades as TKPHF
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jun 17, 2026Score 5/30
$21.64+0.05 (+0.23%)

Close on Nov 17, 2026Market cap $74.58BP/E –Yield –

Takeda Pharmaceutical EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Takeda Pharmaceutical's EV/EBITDA was 20.3× on Nov 11, 2026, against 10.2× a year earlier. Over the last 5 years it ranged from 8.1× to 20.3×, with a median of 10.0×.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202620.3×+9.5
2025Dec 31, 202510.8×−0.9
2024Dec 31, 202411.7×+2.8
2023Dec 29, 20238.8×−0.7
2022Dec 30, 20229.6×+1.5
2021Dec 31, 20218.1×−7.1
2020Dec 31, 202015.2×−9.1
2019Dec 31, 201924.2×+15.6
2018Dec 31, 20188.6×−5.9
2017Dec 29, 201714.5×–

More Takeda Pharmaceutical figures

See a number that looks wrong?